Med Biogene Competitors

Med Biogene (CVE:MBI) and Akumin (TSE:AKU) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, risk, profitability, earnings, analyst recommendations, institutional ownership and valuation.

Profitability

This table compares Med Biogene and Akumin's net margins, return on equity and return on assets.

Analyst Ratings

This is a summary of current ratings and price targets for Med Biogene and Akumin, as provided by MarketBeat.

Akumin has a consensus target price of C$4.25, suggesting a potential upside of 7.59%. Given Akumin's higher possible upside, analysts clearly believe Akumin is more favorable than Med Biogene.

Earnings & Valuation

This table compares Med Biogene and Akumin's top-line revenue, earnings per share and valuation.

Med Biogene has higher earnings, but lower revenue than Akumin. Akumin is trading at a lower price-to-earnings ratio than Med Biogene, indicating that it is currently the more affordable of the two stocks.

Summary

Akumin beats Med Biogene on 3 of the 5 factors compared between the two stocks.

Med Biogene (CVE:MBI) and LexaGene (CVE:LXG) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, valuation, earnings, analyst recommendations, dividends, institutional ownership and risk.

Profitability

This table compares Med Biogene and LexaGene's net margins, return on equity and return on assets.

Analyst Ratings

This is a summary of recent ratings for Med Biogene and LexaGene, as reported by MarketBeat.com.

Valuation & Earnings

This table compares Med Biogene and LexaGene's top-line revenue, earnings per share (EPS) and valuation.

Med Biogene is trading at a lower price-to-earnings ratio than LexaGene, indicating that it is currently the more affordable of the two stocks.

Med Biogene (CVE:MBI) and SQI Diagnostics (CVE:SQD) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, earnings, profitability, valuation and risk.

Analyst Ratings

This is a breakdown of current ratings and price targets for Med Biogene and SQI Diagnostics, as reported by MarketBeat.

Profitability

This table compares Med Biogene and SQI Diagnostics' net margins, return on equity and return on assets.

Earnings and Valuation

This table compares Med Biogene and SQI Diagnostics' revenue, earnings per share (EPS) and valuation.

Med Biogene has higher earnings, but lower revenue than SQI Diagnostics. SQI Diagnostics is trading at a lower price-to-earnings ratio than Med Biogene, indicating that it is currently the more affordable of the two stocks.

Summary

Med Biogene beats SQI Diagnostics on 2 of the 3 factors compared between the two stocks.

Sernova (CVE:SVA) and Med Biogene (CVE:MBI) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, valuation, profitability, analyst recommendations, institutional ownership, risk and dividends.

Earnings & Valuation

This table compares Sernova and Med Biogene's gross revenue, earnings per share (EPS) and valuation.

Sernova is trading at a lower price-to-earnings ratio than Med Biogene, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Sernova and Med Biogene's net margins, return on equity and return on assets.

Analyst Ratings

This is a breakdown of recent recommendations for Sernova and Med Biogene, as provided by MarketBeat.

Summary

Med Biogene beats Sernova on 2 of the 2 factors compared between the two stocks.

Med Biogene (CVE:MBI) and GeneNews (TSE:GEN) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, valuation, dividends, institutional ownership, profitability, earnings and risk.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Med Biogene and GeneNews, as reported by MarketBeat.com.

Profitability

This table compares Med Biogene and GeneNews' net margins, return on equity and return on assets.

Valuation and Earnings

This table compares Med Biogene and GeneNews' revenue, earnings per share (EPS) and valuation.

Med Biogene has higher earnings, but lower revenue than GeneNews. Med Biogene is trading at a lower price-to-earnings ratio than GeneNews, indicating that it is currently the more affordable of the two stocks.

Summary

GeneNews beats Med Biogene on 2 of the 3 factors compared between the two stocks.

LED Medical Diagnostics (CVE:LMD) and Med Biogene (CVE:MBI) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, profitability, institutional ownership, risk, earnings, dividends and analyst recommendations.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for LED Medical Diagnostics and Med Biogene, as provided by MarketBeat.com.

Earnings & Valuation

This table compares LED Medical Diagnostics and Med Biogene's top-line revenue, earnings per share and valuation.

Med Biogene has lower revenue, but higher earnings than LED Medical Diagnostics. LED Medical Diagnostics is trading at a lower price-to-earnings ratio than Med Biogene, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares LED Medical Diagnostics and Med Biogene's net margins, return on equity and return on assets.

Summary

Med Biogene beats LED Medical Diagnostics on 2 of the 3 factors compared between the two stocks.